Sinotherapeutics Inc. (SHA:688247)

Sinotherapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,019	4,355	4,517	4,978	7,593	-
Market Cap Growth	-10.05%	-3.58%	-9.25%	-34.45%	-	-
Enterprise Value	3,241	3,590	3,769	4,194	6,771	-
Last Close Price	8.95	9.70	10.00	10.83	16.44	-
PE Ratio	88.92	91.73	35.37	81.50	81.71	-
PS Ratio	9.30	9.75	8.83	16.60	30.67	-
PB Ratio	3.07	3.37	3.55	4.11	6.45	-
P/TBV Ratio	3.14	3.45	3.66	4.28	6.74	-
P/FCF Ratio	104.17	81.00	127.97	-	-	-
P/OCF Ratio	57.48	45.69	34.69	384.14	103.76	-
EV/Sales Ratio	7.50	8.04	7.37	13.99	27.35	-
EV/EBITDA Ratio	35.71	38.45	27.36	62.24	80.84	-
EV/EBIT Ratio	58.43	58.35	31.55	94.67	116.33	-
EV/FCF Ratio	84.02	66.77	106.79	-	-	-
Debt / Equity Ratio	0	0	0	0	0.00	0.01
Debt / EBITDA Ratio	0.00	0.00	0.00	0.00	0.02	0.04
Debt / FCF Ratio	0	0	0	-	-	0.03
Net Debt / Equity Ratio	-0.59	-0.58	-0.58	-0.62	-0.68	-0.72
Net Debt / EBITDA Ratio	-8.57	-8.00	-5.32	-11.11	-9.62	-4.18
Net Debt / FCF Ratio	-20.15	-13.88	-20.78	28.81	7.81	-3.91
Asset Turnover	0.30	0.31	0.36	0.22	0.23	0.39
Inventory Turnover	3.14	3.09	2.63	2.34	1.96	1.71
Quick Ratio	9.88	10.08	8.19	9.13	9.76	6.21
Current Ratio	10.98	11.27	9.46	10.49	10.59	6.91
Return on Equity (ROE)	3.35%	3.70%	10.29%	5.12%	9.87%	21.29%
Return on Assets (ROA)	2.37%	2.66%	5.31%	2.06%	3.31%	7.41%
Return on Invested Capital (ROIC)	9.27%	10.10%	21.46%	9.84%	19.49%	52.09%
Return on Capital Employed (ROCE)	4.10%	4.50%	8.80%	3.50%	4.70%	12.30%
Earnings Yield	1.08%	1.09%	2.83%	1.23%	1.22%	-
FCF Yield	0.96%	1.23%	0.78%	-0.52%	-1.36%	-
Dividend Yield	0.55%	-	0.62%	0.38%	0.38%	-
Payout Ratio	63.91%	58.63%	21.83%	46.02%	-	-
Buyback Yield / Dilution	2.55%	5.35%	2.92%	-11.22%	-3.32%	-0.21%
Total Shareholder Return	3.09%	5.35%	3.54%	-10.84%	-2.94%	-0.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.